Early Onset and Maintenance Effect of Galcanezumab in Japanese Patients with Episodic Migraine
Hisaka Igarashi,1 Mamoru Shibata,2 Akichika Ozeki,3 Kathleen Ann Day,4 Taka Matsumura3 1Department of Internal Medicine, Fujitsu Clinic, Kawasaki, Japan; 2Department of Neurology, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Japan; 3Eli Lilly Japan K.K., Kobe, Japan; 4Eli Lilly and Comp...
Guardado en:
Autores principales: | Igarashi H, Shibata M, Ozeki A, Day KA, Matsumura T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/93d7c730f96e47338791249a8e85b85d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
por: Stephanie J. Nahas, et al.
Publicado: (2021) -
Exploring the Hereditary Nature of Migraine
por: Bron C, et al.
Publicado: (2021) -
Effect of a Mindfulness-Based Intervention for Chronic Migraine and High Frequency Episodic Migraine in Adolescents: A Pilot Single-Arm Open-Label Study
por: Licia Grazzi, et al.
Publicado: (2021) -
Economic analysis of acupuncture for migraine prophylaxis
por: Pokladnikova J, et al.
Publicado: (2018) -
The role of diet in the prevention of migraine attacks
por: O. O. Kopchak, et al.
Publicado: (2021)